Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Boehringer Ingelheim
Baxter
Express Scripts
Moodys
Dow

Last Updated: April 5, 2020

DrugPatentWatch Database Preview

DrugPatentWatch Database Updates: New Patent Delistings

» See Plans and Pricing

« Back to Dashboard

DrugPatentWatch Database Updates: New Patent Delistings

These are patents which have been reported by the FDA since the last major update; they are not yet in the main database.
Glossary
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Usecode Patented / Exclusive Use
Teva Pharms Usa COPAXONE glatiramer acetate INJECTABLE 020622 Dec 20, 1996 DISCN No   Start Trial   Start Trial U-441 METHOD OF TREATING MS BY ADMINISTERING COPAXONE
Teva Pharms Usa COPAXONE glatiramer acetate INJECTABLE 020622 Feb 12, 2002 RX Yes   Start Trial   Start Trial U-441 METHOD OF TREATING MS BY ADMINISTERING COPAXONE
Teva Pharms Usa COPAXONE glatiramer acetate INJECTABLE 020622 Jan 28, 2014 RX Yes   Start Trial   Start Trial U-441 METHOD OF TREATING MS BY ADMINISTERING COPAXONE
Teva Pharms Usa COPAXONE glatiramer acetate INJECTABLE 020622 Dec 20, 1996 DISCN No   Start Trial   Start Trial U-441 METHOD OF TREATING MS BY ADMINISTERING COPAXONE
Teva Pharms Usa COPAXONE glatiramer acetate INJECTABLE 020622 Feb 12, 2002 RX Yes   Start Trial   Start Trial U-441 METHOD OF TREATING MS BY ADMINISTERING COPAXONE
Teva Pharms Usa COPAXONE glatiramer acetate INJECTABLE 020622 Jan 28, 2014 RX Yes   Start Trial   Start Trial U-441 METHOD OF TREATING MS BY ADMINISTERING COPAXONE
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Type >RLD >Patent No. >Patent Expiration >Usecode >Patented / Exclusive Use

Subscribe to access the full database, or Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Colorcon
Medtronic
Johnson and Johnson
McKesson
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
Copyright 2002-2020 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2020 - 2021
 NCE-1 Patent Challenge Dates 2020 - 2021
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2020, www.DrugPatentWatch.com.

Links

Follow DrugPatentWatch:

  DrugPatentWatch Linkedin Group

DrugPatentWatch reviews